Genmab A/S (GNMSF)

Last Closing Price: --

EBITDA (Annual)

EBITDA: Income before interest, taxes, depreciation and amortization.

Genmab A/S (GNMSF) had EBITDA of $1.14B for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$3.72B
$963.00M
$238.00M
$3.48B
$2.65B
$1.06B
$139.00M
$1.20B
$1.20B
$963.00M
$963.00M
$963.00M
$963.00M
$1.06B
EBITDA
$1.14B
62.15M
62.69M
$15.50
$15.37
Balance Sheet Financials
$2.88B
$153.00M
$9.99B
$12.87B
$1.43B
$5.00B
$5.60B
$7.03B
$5.85B
$-3.63B
$5.85B
64.24M
Cash Flow Statement Financials
$1.19B
$-5.64B
$4.79B
$1.38B
$1.72B
$335.00M
$128.00M
--
--
Fundamental Metrics & Ratios
2.02
--
--
0.46
0.90
93.60%
28.63%
28.63%
30.54%
32.37%
25.89%
$-6.07B
--
--
--
0.29
13.22
3.23
113.03
16.47%
-26.52%
7.48%
8.88%
$91.02
$-96.76
$18.92